Altair Engineering is a technology company providing software and cloud solutions in the areas of product design and development, cloud computing, and data intelligence. The company's Software segment includes software and software related services. The software component of this segment includes its portfolio of software products including its solvers and optimization technology products. The company's client engineering services (CES), segment provides client engineering services to support its customers with long-term ongoing capability. The company operates its CES business by hiring engineers for placement at a customer site for specific customer-directed assignments.
Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company has three platforms: its Oncology Innovation Platform, dedicated to the research and development of its proprietary drugs; its Commercial Platform, focused on the sales and marketing of its specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src Kinase inhibition, T-cell Receptor-engineered T-cells, and arginine deprivation therapy.
Hersha Hospitality Trust is a real estate investment trust. The company invests primarily in institutional grade hotels in primary urban gateway markets including New York, Washington, District of Columbia, Boston, Philadelphia, South Florida and select markets on the West Coast. The company owns its hotels and its investments in joint ventures through its operating partnership, Hersha Hospitality Limited Partnership, for which the company serves as the sole general partner. The majority of the company's wholly-owned hotels are managed by Hersha Hospitality Management, L.P., a management company owned by certain of its trustees and executive officers and other unaffiliated third party investors.
Principia Biopharma is a late-stage biopharmaceutical company. The company has produced three new drug candidates from its platform. The company's key drug candidate, PRN1008, is designed to form a reversible covalent bond with the Bruton's Tyrosine Kinase (BTK) enzyme. The second drug candidate in the company's BTK franchise is PRN2246/SAR442168, an irreversible covalent BTK inhibitor that it designed to cross the blood-brain barrier and modulate immune cell function in the brain for the treatment of multiple sclerosis, and potentially other central nervous system. PRN1371, an additional wholly owned drug candidate, is an inhibitor of Fibroblast Growth Factor Receptor designed for the treatment of solid tumors.
Sears Hometown & Outlet Stores is a national retailer primarily focused on selling home appliances, lawn and garden equipment, tools, and hardware at its stores and on its websites. The company's segments include: Sears Hometown, where Hometown stores are designed to provide its customers with in-store and online access to a selection of national brands of home appliances, lawn and garden equipment, tools, sporting goods, and household goods, depending on the particular store; and Sears Outlet, where Outlet stores are designed to provide in-store and online access to purchase new, out-of-carton, discontinued, obsolete, used, reconditioned, overstocked, and scratched and dented products.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.